COVID-19对慢性阻塞性肺病的长期影响
Chi-Tai Lee1, Ping-Huai Wang1,2,3, Shih-Lung Cheng1,4
1Division of Pulmonology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
概括
患有2019年冠状病毒病 (COVID-19) 感染慢性阻塞性肺病 (COPD) 的患者面临更高的死亡率和更频繁的严重恶化. 这些风险无论住院或门诊状态如何,都会持续存在,这凸显了需要谨慎管理的必要性.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 慢性阻塞性肺病 (COPD) 是2019年冠状病毒病 (COVID-19) 患者已知的负预后因素.
- 由于研究有限,COPD患者的COVID-19的长期并发症尚未得到充分了解.
研究的目的:
- 研究COPD患者COVID-19的临床结果和长期并发症.
- 为了比较COPD患者与COVID-19患者之间的特征,恶化和生存率.
主要方法:
- 从2020年1月到2022年12月,对696名COPD患者进行了回顾性研究.
- 分类为COVID-19 (n=86) 和非COVID-19 (n=610) 组.
- 对人口统计,临床特征,COPD急性恶化 (AECOPD) 和生存率的比较分析,对住院患者和门诊患者的COVID-19病例进行亚组分析.
主要成果:
- COVID-19组年龄较大 (75.0与72.0岁),死亡率较高 (4.6%与0%) 和AECOPD频率较高 (0.17与0.08每年).
- COVID-19感染是AECOPD发病率增加的一个独立风险因素 (aOR: 1.74;95%CI: 1.07-2.83).
- 在COVID-19组中,住院患者心力衰竭率较高 (20%对2.8%),强迫活力能力较低,与门诊患者相比.
结论:
- 年龄是COPD患者COVID-19的重要危险因素.
- 在COPD患者中,COVID-19感染增加了严重恶化和死亡风险的频率.
- 在COVID-19后,对严重恶化的敏感性增加是独立于护理环境 (住院/门诊).
相关概念视频
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
COPD: Pathogenesis and Clinical Features
529
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
529
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K


